See the 2,456 pharmacies on the National E-Pharmacy Platform
Alk abello a-s – product pipeline review – 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
ALK-Abello A/S – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Market Direct’s pharmaceuticals report, “ALK-Abello A/S - Product Pipeline
Review - 2012” provides data on the ALK-Abello A/S’s research and development
focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, ALK-Abello A/S’s corporate website, SEC filings, investor
presentations and featured press releases, both from ALK-Abello A/S and industry-
specific third party sources, put together by Global Markets Direct’s team.
Scope
- ALK-Abello A/S - Brief ALK-Abello A/S overview including business description,
key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ALK-Abello A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 4
2. List of Figures 4
ALK-Abello A/S Snapshot 5
ALK-Abello A/S Overview 5
Key Information 5
Key Facts 5
ALK-Abello A/S – Research and Development Overview 6
Key Therapeutic Areas 6
ALK-Abello A/S – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
ALK-Abello A/S – Pipeline Products Glance 10
ALK-Abello A/S – Late Stage Pipeline 10
Registration Filed Products/Combination Treatment Modalities 10
Phase III Products/Combination Treatment Modalities 11
ALK-Abello A/S Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
ALK-Abello A/S – Drug Profiles 14
ALK Birch Pollen Vaccine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ALK Ragweed Vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Grazax 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Mitizax 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Osiris 20
Product Description 20
3. Mechanism of Action 20
R&D Progress 20
ALK-Abello A/S – Pipeline Analysis 21
ALK-Abello A/S – Pipeline Products by Therapeutic Class 21
ALK-Abello A/S – Pipeline Products by Route of Administration 22
ALK-Abello A/S – Recent Pipeline Updates 23
ALK-Abello A/S - Dormant Projects 24
ALK-Abello A/S – Company Statement 25
ALK-Abello A/S – Locations And Subsidiaries 26
Head Office 26
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Achillion Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Addex Therapeutics – Product Pipeline Review – 2012
Adherex Technologies Inc. – Product Pipeline Review – 2012
Alchemia Limited – Product Pipeline Review – 2012
4. ALK-Abello A/S – Product Pipeline Review – 2012
Onchocerciasis (River Blindness) – Pipeline Review, H1 2012
Seborrhea – Pipeline Review, H1 2012
Cerebral Palsy – Pipeline Review, H1 2012
Hemolytic Disease In Newborns – Pipeline Review, H1 2012
Panic Disorders – Pipeline Review, H1 2012
4SC AG – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com